Harvest Capital Management

BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

Qinghai Lihao specializes in the research, development, production, and sales of crystalline silicon, particularly for use in semiconductor materials. The company is dedicated to mass production of high-purity crystalline silicon, which supports the renewable energy sector and meets the demands of clients in the semiconductor industry. By focusing on process technology, Qinghai Lihao aims to advance its capabilities in the new energy business while ensuring the availability of essential materials for various applications.

Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of services, including clinical testing, medical device manufacturing, and scientific cooperation related to precision medicine. Operating in approximately 100 hospitals, Beijing Gene+ Technology has supported thousands of cancer patients across the country, contributing to advancements in personalized healthcare and tumor treatment strategies.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Cellix Software is a provider of integrated circuit (IC) design assistance software and services, focusing on the semiconductor industry. The company specializes in technology analysis, intellectual property infringement analysis, and chip design services, supporting clients in navigating the complexities of IC development. Cellix has independently developed a suite of five electronic design automation (EDA) software systems, which cover the comprehensive process of integrated circuit technology analysis and intellectual property protection. By offering these services, the company aims to enhance the efficiency with which its clients can bring their semiconductor products to market.

Pinpianyi is a Hangzhou-based start-up focused on creating a smart procurement platform tailored for convenience stores. The company's innovative platform leverages artificial intelligence technology to offer product price data analysis and intelligent ordering services, which assist retailers in optimizing their procurement processes. By facilitating connections between over 10,000 offline stores and more than 1,000 suppliers, Pinpianyi aims to minimize procurement and logistics costs, enhance capital turnover efficiency, and reduce inventory backlog for its clients. Through its advanced technological solutions, the company seeks to streamline operations within the convenience store sector and support sustainable growth.

Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.

Beijing Easyhome Furnishing Chain Store Group Company is a prominent Chinese retailer specializing in home improvement and furniture. With 223 physical stores across 29 provinces, it is the country's second-largest player in this sector, offering a wide range of home furnishing and DIY-style products.

A fast food chain brand based in Anhui province.

Channelsoft (Beijing) Technology Co., Ltd. is a prominent provider of communications software products and services in Mainland China, founded in 2000 and headquartered in Beijing. The company specializes in telecom value-added service platforms and call center platforms that cater to various sectors, including telecommunications, finance, government, post, and media. Channelsoft is recognized for its strong research and development focus on technologies that integrate communications, computer, and cable television networks. As a leader in the domestic market, the company offers solutions for creating, deploying, managing, and operating value-added business and interactive services, as well as promoting trans-platform solutions to unify multiple networks.

51 Credit Card Inc. is an investment holding company based in Hangzhou, China, that operates an online credit card management platform. Founded in 2012 by Sun Haitao, the company primarily offers the 51 Credit Card Manager app, which helps users manage their credit card bills. In addition to personal credit management, 51 Credit Card provides a range of financial services including credit card technology, online credit facilitation, prepaid card issuance, internet payment services, and loan collection. The company also offers micro loan products, financing guarantees, post-loan management, insurance broking, and consulting services. By developing and operating various apps, alongside fund sales, 51 Credit Card aims to enhance personal financial management for its users in the People's Republic of China.

In recent years, tourism has changed all around the world with the post-90s generation becoming increasingly important. Unlike previous generations they are not satisfied with group tours or cursory sightseeing trips. Rather, they are looking for more meaningful experiences through which to enrich their lives and help them standout. Hive was born to meet these needs. We have gathered many experienced travelers and travel experts and the team keeps growing every day. Over 100,000 young people have had their lives enhanced through Hive.

Shouqi Limousine & Chauffeur is a Beijing-based company that operates a ride-booking application, offering mobility services throughout China. Established in 2015, it serves as a subsidiary of the state-owned Shouqi Group. The company specializes in providing various transportation solutions, including limousine services, to meet the growing demand for convenient and reliable travel options in urban areas.

Yitiao is an online video content producer and e-commerce start-up.